letrozole has been researched along with Heart Defects, Congenital in 1 studies
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole is an effective drug for ovulation induction and superovulation." | 1.34 | Limiting access to letrozole--is it justified? ( DeCherney, AH; Tulandi, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tulandi, T | 1 |
| DeCherney, AH | 1 |
1 other study available for letrozole and Heart Defects, Congenital
| Article | Year |
|---|---|
Limiting access to letrozole--is it justified?
Topics: Aromatase Inhibitors; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infertility, Femal | 2007 |